Endocrine Cancer: Clinical Trials

3 trials for Endocrine Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Not yet recruiting 1

Follow Endocrine Cancer: new trials by email Literature Review of Endocrine Cancer trials Research Report on Endocrine Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy - Advanced Cancer, Stage IV Solid Tumor Cancer
Phase 2Not yet recruitingUniversity Health Network, Toronto462026-09-142026-10-15
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
Psilocybin - Advanced Cancer, Stage IV Solid Tumor Cancer
Phase 2Active not recruitingUniversity Health Network, Toronto152024-06-062026-06-22
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
denosumab - Breast Cancer, Hypercalcemia of Malignancy
Phase 2CompletedAmgen332009-11-162018-10-17

Narrower conditions

Endocrine Gland Neoplasms (3)  ·  Lymphoma (3)  ·  Melanoma (2)  ·  Osteosarcoma (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Humoral Hypercalcemia Of Malignancy (1)  ·  Hypercalcemia (1)  ·  Kidney Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)

Broader conditions

Endocrine System Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Neoplasms (2)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Germ Cell and Embryonal (2)

Interventions

Psilocybin (2)  ·  Denosumab (1)

Sponsors

University Health Network, Toronto (2)  ·  Amgen (1)

Countries

Canada (3)  ·  France (1)  ·  Italy (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Sarah Hales, MD (1)

Results publications

PMID 23990665, PMID 41152967